ChromaDex Corporation (NASDAQ: CDXC)
$3.08
+0.3100 ( +11.19% ) 513.8K
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
Market Data
Open
$3.08
Previous close
$2.77
Volume
513.8K
Market cap
$213.02M
Day range
$2.77 - $3.11
52 week range
$1.25 - $4.65
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 36 | May 08, 2024 |
10-q | Quarterly Reports | 68 | May 08, 2024 |
ars | Annual reports | 1 | Apr 25, 2024 |
def | Proxies and info statements | 19 | Apr 25, 2024 |
10-k | Annual reports | 109 | Mar 06, 2024 |
8-k | 8K-related | 41 | Mar 06, 2024 |
4 | Insider transactions | 1 | Feb 23, 2024 |
4 | Insider transactions | 1 | Feb 23, 2024 |
8-k | 8K-related | 14 | Dec 13, 2023 |
4 | Insider transactions | 1 | Dec 04, 2023 |